Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 264,730 | reported | 03 Mar 2025 | tx 81+591,698−398,729 |
| Passage BIO, Inc. | 10,539 | reported | 19 May 2026 | tx 3+328,467 |
| INTERMUNE INC | 0 | reported | 28 Dec 2007 | tx 29+173,081−252,396 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Passage BIO, Inc. | 10,539 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Passage BIO, Inc. | 143,789 | 0.00 USD | deriv |
| 03 Mar 2025 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 508 | 42.92 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 18,443 | 0.00 USD | |
| 03 Mar 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 6,028 | 42.10 USD | |
| 30 Sept 2024 | GRANT_AWARD | Passage BIO, Inc. | 174,139 | 0.00 USD | deriv |
| 11 Mar 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 11,509 | 49.93 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 17,800 | 0.00 USD | |
| 01 Mar 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 1,011 | 53.76 USD | |
| 01 Mar 2024 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 274 | 53.69 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 957 | 0.00 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 31,400 | 0.00 USD | deriv |
| 23 Oct 2023 | SALE | Ultragenyx Pharmaceutical Inc. | 39,878 | 32.78 USD | |
| 23 Oct 2023 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 39,878 | 6.86 USD | |
| 23 Oct 2023 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 39,878 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,663 | 0.00 USD | |
| 01 Mar 2023 | OTHER | Ultragenyx Pharmaceutical Inc. | 3,394 | 45.65 USD | |
| 01 Mar 2023 | SALE | Ultragenyx Pharmaceutical Inc. | 1,968 | 45.27 USD | |
| 01 Mar 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 22,000 | 0.00 USD | |
| 01 Mar 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 39,400 | 0.00 USD | deriv |
| 11 Mar 2022 | SALE | Ultragenyx Pharmaceutical Inc. | 10,281 | 67.01 USD | |
| 01 Mar 2022 | SALE | Ultragenyx Pharmaceutical Inc. | 2,374 | 66.62 USD | |
| 01 Mar 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 14,000 | 0.00 USD | |
| 01 Mar 2022 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 24,900 | 0.00 USD | deriv |
| 10 Dec 2021 | GIFT | Ultragenyx Pharmaceutical Inc. | 52 | 0.00 USD |